Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo

Por Foy, Kevin C., Miller, Megan J., Moldovan, Nicanor, Carson, William E., Kaumaya, Pravin T. P.
Publicado em 2012

Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti...

Por Foy, Kevin C., Miller, Megan J., Moldovan, Nicanor, Carson, William E., Kaumaya, Pravin P.T.
Publicado em 2013

Immunotherapy with HER-2 and VEGF peptide mimics plus metronomic paclitaxel causes superior antineoplastic effects in transplantable and transgenic mouse models of human breast can...

Por Foy, Kevin C., Miller, Megan J., Moldovan, Nicanor, Bozanovic, Tatjana, Carson, William E., Kaumaya, Pravin T. P.
Publicado em 2012

IGF-1R peptide vaccines/mimics inhibit the growth of BxPC3 and JIMT-1 cancer cells and exhibit synergistic antitumor effects with HER-1 and HER-2 peptides

Por Foy, Kevin Chu, Miller, Megan J, Overholser, Jay, Donnelly, Siobhan M, Nahta, Rita, Kaumaya, Pravin TP
Publicado no Oncoimmunology (2014)

Peptide Vaccines and Peptidomimetics of EGFR (HER-1) Ligand Binding Domain Inhibit Cancer Cell Growth In Vitro and In Vivo

Por Foy, Kevin Chu, Wygle, Ruthie M., Miller, Megan J., Overholser, Jay P., Bekaii-Saab, Tanios, Kaumaya, Pravin T. P.
Publicado no J Immunol (2013)